Fifty Milligrams: The Number That Explains What DHEA Can and Can’t Do

Here’s the number I can’t stop staring at: 50 milligrams a day. It shows up twice in the DHEA literature, in two studies asking two very different questions, and both times it’s the dose where something measurable actually happens. That coincidence is, I think, the real story hiding underneath a supplement most people know only as a bottle on the vitamin shelf.

The pitch, and why it isn’t crazy

Start with the biology, because it’s genuinely interesting. Dehydroepiandrosterone is a steroid hormone, made mostly by the adrenal glands, and it circulates in the blood in a sulfated form (DHEA-S) that labs measure directly. By sheer quantity, it’s one of the most abundant steroid hormones the body produces. But abundance isn’t the interesting part. The interesting part is that DHEA is a precursor, a raw material the body converts, downstream, into testosterone and into estradiol [1]. The NIH’s own fact sheet says as much.

So the marketing logic isn’t invented from nothing. Testosterone and estrogen do real things in the body. DHEA is what the body turns into both. Supply more of the raw material, the argument goes, and you get more of the finished product, and the benefits that come with it. That’s a coherent hypothesis. It is not, on its own, evidence.

The hook, and the leap nobody questions

The reason DHEA sells at all is that levels decline with age, sharply, from a peak in a person’s twenties down to a fraction of that by the seventh or eighth decade. Nobody disputes that curve.

What deserves more scrutiny is the leap from “this number falls as you age” to “restoring the number reverses the things you dislike about aging.” A level dropping on schedule is not automatically a deficiency. Almost nobody buying DHEA off a shelf has had their level checked. They’re betting that more of a naturally declining hormone equals better, which is a wager, not a diagnosis. So what happens when that wager gets tested in an actual trial?

Where the trial evidence is honest, and where it’s thin

The cleanest test case is people who have a genuine, documented shortfall: primary adrenal insufficiency, including Addison’s disease, where the adrenal glands simply can’t make enough hormone. A randomized, controlled trial in the Journal of Clinical Endocrinology and Metabolism put 106 of these patients on either 50 milligrams of DHEA daily or placebo, for twelve months [3]. There it is again, that number. And the result wasn’t nothing: a gain in lean body mass, a halt to bone loss at the femoral neck, and improvement on one quality-of-life subscale. Real outcomes, from a real control group.

But read the same trial for what it didn’t find, and the enthusiasm cools fast. No benefit for fat mass. No benefit for fatigue. No benefit for cognition. Even in the one population where the rationale for supplementing is airtight, the payoff was partial.

Now compare that to where the actual sales happen, which is mostly aging adults and women in menopause, buying on the promise of vitality and energy rather than a diagnosed adrenal problem. The best evidence here is a Cochrane review, pooling 28 randomized trials across more than 1,200 peri- and postmenopausal women, and its conclusion is blunt: no evidence that DHEA improves quality of life, and some evidence it causes androgenic side effects, acne being the most common [2]. The one soft spot of possible benefit was sexual function, described as maybe slightly better than placebo, with the effect on general menopausal symptoms called unclear. That’s the gap between what’s on the label and what the strongest available synthesis actually found, and it’s not a small gap.

Athletic performance fares no better. The NIH’s review of the research states plainly that the minimal work done on DHEA for exercise and athletic performance shows no evidence of benefit [1]. Not “inconclusive.” No evidence.

The counterpoint: this stuff clearly does something

Here’s where I want to push back on my own skepticism, because DHEA is not a sugar pill. A dose-response meta-analysis of randomized trials found that it significantly raises estradiol levels in women, by a weighted mean difference of roughly 7 picograms per milliliter, with the effect strongest in women 60 and older, at doses around 50 milligrams a day, over 26 weeks or longer [4]. There’s that number a third time, structurally, if you count it as the same dose band across two separate bodies of research.

That finding is often waved around as proof DHEA “works.” I’d read it the opposite way. It confirms the mechanism is real, the molecule does move hormones, which is precisely why the androgenic side effects Cochrane flagged show up in the first place [2]. A substance that measurably shifts your estrogen isn’t a wellness perk. It’s a pharmacological effect, and pharmacological effects are the kind of thing you want a clinician watching, not the kind of thing you want guessed from a label on a shelf.

The one approved product, and what it doesn’t cover

There’s a single spot where DHEA crosses from supplement into regulated drug, and it’s worth isolating precisely because it gets stretched further than it should. In 2016 the FDA approved prasterone, a vaginal insert whose active ingredient is DHEA, for one narrow indication: moderate to severe pain during intercourse caused by vulvar and vaginal atrophy in postmenopausal women [5]. That’s a specific, local, trial-backed use. It says nothing about whether an oral capsule does anything for energy or aging, and treating the approval as a halo over the whole category is a misread I’d flag every time I see it.

So what does the 50-milligram convergence actually tell us?

Pull the threads together and the pattern is this: the dose that produced modest, real benefit in a diagnosed-deficiency population is the same dose band that reliably raises estradiol in the broader population being marketed to. That’s not a coincidence to celebrate, it’s a coincidence to respect. It means the “active” dose and the “risk” dose sit in roughly the same neighborhood, which is exactly the situation where guessing your own dosage is a bad idea and where having a clinician set it against actual labs is not overcaution, it’s just how you’d treat any other hormone.

None of this makes DHEA useless. It makes it narrow: real relief for a specific, diagnosed deficiency, a possible small assist for sexual function in menopausal women, one approved local product for one specific symptom, and, everywhere else the marketing points, energy, anti-aging, athletic edge, a research record that doesn’t back the promise [1][2]. Supervised-access telehealth setups like FormBlends exist for exactly this kind of substance: a clinician decides whether it’s warranted, a licensed pharmacy fills it, and someone is actually watching for the estradiol shift the data says to expect. That structure doesn’t make the underlying science any less mixed. It just means the mixed science gets acted on by someone paying attention, rather than by a bottle and a guess.

Questions people keep asking me

Does DHEA actually do anything for anti-aging or energy?

Not according to the trial data. The uses that get marketed hardest, anti-aging, energy, mood, body composition, are the ones where controlled research keeps coming up empty, and the NIH’s own read on athletic performance is explicitly “no evidence of benefit” [1]. The real signal sits somewhere else entirely: diagnosed adrenal insufficiency, not healthy aging.

Who actually has a good reason to take it?

People with primary adrenal insufficiency, including Addison’s disease, whose adrenal glands genuinely can’t produce enough hormone on their own. The twelve-month controlled trial in that group found modest lean-mass gains, a halt to bone loss at the femoral neck, and improvement on one quality-of-life measure [3]. It’s a real result with real limits, and it doesn’t extend to someone whose level is simply doing what levels do with age.

Isn’t a falling DHEA level basically a deficiency?

No, and this is the confusion the marketing leans on. The decline from a person’s twenties onward is a normal feature of aging, not evidence of a shortfall needing correction. Most buyers have never had their level tested, so they’re acting on a hunch, more of a declining hormone equals better, and treating that hunch as settled fact.

If the supplement evidence is weak, why is there an FDA-approved DHEA drug?

The approved product, prasterone, sold as a vaginal insert, is cleared for one narrow local indication: moderate to severe pain during intercourse from vulvar and vaginal atrophy in postmenopausal women [5]. That’s a specific, tested use, not a stamp of approval on oral capsules sold for vitality.

Does it help with menopause symptoms?

Mostly, no. The Cochrane review pooling 28 trials in over 1,200 women found no evidence of a quality-of-life benefit and some evidence of androgenic side effects like acne [2]. The one place a small possible benefit showed up was sexual function, with the broader symptom picture called unclear.

What dose do the actual studies use?

Around 50 milligrams a day, both in the adrenal insufficiency trial and in the estradiol meta-analysis [3][4]. Shelf products commonly range from a few milligrams up to 25 or 50, sometimes more. Given that this is a hormone with a genuine dose-response curve, where the effective range and the risk range appear to overlap, the sensible move is letting a clinician match a dose to your labs rather than picking a number off a label.

What side effects can DHEA supplements cause?

Because it raises androgen levels, acne, oily skin, and unwanted facial hair are real, common complaints, especially in women. Some men report breast tenderness or moodiness. At higher doses, both sexes have reported hair thinning and irritability. Since DHEA converts to both estrogen and testosterone in the body, anyone with a hormone-sensitive condition, certain cancers included, shouldn’t touch it without a physician’s sign-off.

Does taking DHEA cause weight gain?

There’s no consistent evidence of that. A handful of small trials in older adults showed modest drops in abdominal fat, not gains, though the effect isn’t dramatic or reliable across studies. What can happen is some water retention or a shift in body composition if androgen levels climb noticeably. Expecting it to reshape your body on its own isn’t supported by what’s actually been measured.

Is long-term use safe?

Honestly, nobody has a solid answer. Most trials run months, not years, so the long-term safety picture is thin. Short-term, moderate-dose use looks reasonably tolerable in healthy adults, but the downstream effects on estrogen and testosterone mean sustained, unsupervised use carries real unknowns. For anyone with a genuine reason to consider it, going through a physician-supervised route, a compounding pharmacy such as FormBlends, builds in the monitoring that grabbing a bottle off a shelf skips entirely.

What is DHEA actually doing in the body, in plain terms?

It’s a steroid hormone, made mainly by the adrenal glands, that functions as raw material, convertible into testosterone or estrogen depending on what the body is doing with it. Production peaks in your mid-twenties and declines steadily afterward. It doesn’t have one single job, which is a big part of why the research on supplementing it stays so mixed.

References

1. Dietary Supplements for Exercise and Athletic Performance: DHEA section, Health Professional Fact Sheet, NIH Office of Dietary Supplements. States that DHEA is sold over the counter as a supplement, that the body converts it to testosterone and estradiol, and that the minimal research on DHEA for exercise and athletic performance provides no evidence of benefit. https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/
2. Scheffers CS, Armstrong S, Cantineau AEP, Farquhar C, Jordan V. Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Cochrane Database Syst Rev. 2015;(1):CD011066. PMID: 25879093. Pooled 28 randomized trials in more than 1,200 women, concluding there is no evidence DHEA improves quality of life, some evidence of androgenic side effects (mainly acne), unclear effect on menopausal symptoms, and a possible small improvement in sexual function. https://pubmed.ncbi.nlm.nih.gov/25879093/
3. Gurnell EM, Hunt PJ, Curran SE, et al. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab. 2008;93(2):400-409. PMID: 18000094. In 106 patients with primary adrenal insufficiency taking 50 mg DHEA or placebo for 12 months, DHEA improved one quality-of-life subscale, increased lean body mass, and reversed bone loss at the femoral neck, without changing fat mass, fatigue, or cognition.
4. The effect of dehydroepiandrosterone (DHEA) supplementation on estradiol levels in women: a dose-response and meta-analysis of randomized clinical trials. Steroids. 2021;174:108889. PMID: 34246664. Across 21 arms and 1,223 participants, DHEA significantly increased estradiol (weighted mean difference about 7.02 pg/mL), with larger effects in women aged 60 and older, at 50 mg/day, and over durations of 26 weeks or more.
5. INTRAROSA (prasterone) vaginal insert, U.S. Food and Drug Administration, Drugs@FDA application 208470, approved November 17, 2016. The active ingredient prasterone is dehydroepiandrosterone (DHEA); the product is indicated only for moderate to severe dyspareunia (pain during intercourse) due to vulvar and vaginal atrophy in postmenopausal women.